Unknown

Dataset Information

0

Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.

ABSTRACT: Despite the existence of flu vaccines and small-molecule antiviral drugs, influenza virus infection remains a public health concern that warrants immediate attention. As resistance to the only orally bioavailable drug, oseltamivir, has been continuously reported, there is a clear need to develop the next-generation of anti-influenza drugs. We chose the influenza A virus M2-S31N mutant proton channel as the drug target to address this need as it is one of the most conserved viral proteins and persist in >95% of currently circulating influenza A viruses. In this study, we report the development of a late-stage diversification strategy for the expeditious synthesis of M2-S31N inhibitors. The channel blockage and antiviral activity of the synthesized compounds were tested in two-electrode voltage clamp assays and antiviral assays, respectively. Several M2-S31N inhibitors were identified to have potent M2-S31N channel blockage and micromolar antiviral efficacy against several M2-S31N-containing influenza A viruses.

SUBMITTER: Li F 

PROVIDER: S-EPMC5505239 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.

Li Fang F   Ma Chunlong C   Hu Yanmei Y   Wang Yuanxiang Y   Wang Jun J  

ACS infectious diseases 20160922 10

Despite the existence of flu vaccines and small-molecule antiviral drugs, influenza virus infection remains a public health concern that warrants immediate attention. As resistance to the only orally bioavailable drug, oseltamivir, has been continuously reported, there is a clear need to develop the next-generation of anti-influenza drugs. We chose the influenza A virus M2-S31N mutant proton channel as the drug target to address this need as it is one of the most conserved viral proteins and per  ...[more]

Similar Datasets

Unknown Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
| S-EPMC4829348 | biostudies-literature
Unknown Crystal structure of the drug-resistant S31N influenza M2 proton channel.
| S-EPMC4972211 | biostudies-literature
Unknown Where does amantadine bind to the influenza virus M2 proton channel?
| S-EPMC2919587 | biostudies-literature
Unknown Amantadine-induced conformational and dynamical changes of the influenza M2 transmembrane proton channel.
| S-EPMC2234170 | biostudies-literature
Unknown Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N).
| S-EPMC4306489 | biostudies-literature
Unknown Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.
| S-EPMC4286326 | biostudies-literature
Unknown Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
| S-EPMC2776279 | biostudies-literature
Unknown Backbone structure of the amantadine-blocked trans-membrane domain M2 proton channel from Influenza A virus.
| S-EPMC1877758 | biostudies-literature
Unknown An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
| S-EPMC5326599 | biostudies-literature
Unknown Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
| S-EPMC6496959 | biostudies-literature